HOME › DRUGS › REVUMENIB CITRATE
ACTIVE SUBSTANCE / INN

REVUMENIB CITRATE

Brand name(s): REVUFORJ
FDA LISTED
PRESCRIPTION
NDA218944
ACTIVE SUBSTANCE
Revumenib Citrate
REGULATORS
FDA
SPONSORS / MAH
SYNDAX
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
REVUFORJNDA218944SYNDAXPrescription

FULL INTELLIGENCE ON REVUMENIB CITRATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →